Not only immunogenic neoantigens affect the ability of T cells to identify and kill tumor cell, but mutations in immunologically relevant genes can also do, for example; mutations in JAK1, JAK2, B2M, and STK11genes (Skoulidis et al., 2018). This evidence concerns the gene B2M and neoplasm.